They are prescribed for conditions such as type 2 diabetes, obesity, and certain cardiometabolic risks, depending on the medication and indication
People with silent genetic thinning Sometimes semaglutide doesnt cause the shed it simply reveals what was already developing
Similarly, a study involving semaglutide at 1 mg resulted in an average weight loss of 5.2 kg over 16 weeks in obese women with PCOS
GLP-1 users are not anti-alcohol, they are anti-excess, explains Leigh ODonnell, head of shopper and category insights at Kantar
The experiments were performed at 25 C in the early afternoon
The difficulty being that theres no data to support that, and in fact, the data very clearly suggest the opposite. She said the concern is patients who follow that guidance will have worse health outcomes, and all parties become disillusioned with the promise of GLP-1s